Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UB-221 as an Add-on Therapy in CSU Patients (clinicaltrials.gov) - Apr 3, 2019 - P1; N=15; Recruiting; Sponsor: United BioPharma; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open
|